MoneyWorks4Me

A fair growth of 9.38% in the revenue at Rs. 890.58 millions was reported in the March 2024 quarter as compared to Rs. 814.20 millions during year-ago period.The Net Profit of the company vaulted to 245.80% to Rs. 129.12  millions from Rs. 37.34 millions in the previous quarter.Operating profit surged to 200.12 millions from the corresponding previous quarter of 96.02 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 890.58 814.20 9.38 3624.62 3415.64 6.12 3624.62 3415.64 6.12
Other Income 104.43 0.09 115933.33 575.52 153.96 273.81 575.52 153.96 273.81
PBIDT 200.12 96.02 108.41 1044.32 597.40 74.81 1044.32 597.40 74.81
Interest 0.68 1.13 -39.82 3.21 4.56 -29.61 3.21 4.56 -29.61
PBDT 199.44 94.89 110.18 1041.11 592.84 75.61 1041.11 592.84 75.61
Depreciation 18.30 22.99 -20.40 68.25 85.48 -20.16 68.25 85.48 -20.16
PBT 181.14 71.90 151.93 972.86 507.36 91.75 972.86 507.36 91.75
TAX 52.02 34.56 50.52 218.66 145.61 50.17 218.66 145.61 50.17
Deferred Tax 8.85 -8.54 -203.63 42.76 -13.96 -406.30 42.76 -13.96 -406.30
PAT 129.12 37.34 245.80 754.20 361.75 108.49 754.20 361.75 108.49
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 22.47 11.79 90.54 28.81 17.49 64.73 28.81 17.49 64.73
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..